Company Filing History:
2 out of 525 
5 out of 832,843 Years Active: 2001-2004
Title: The Innovative Contributions of Elke Jäger
Introduction
Elke Jäger is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of cancer research through her innovative inventions. With a total of 7 patents, her work focuses on the development of therapeutic and diagnostic tools that target cancer-associated antigens.
Latest Patents
Among her latest patents is the invention of isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules. This invention relates to peptides that are useful in various therapeutic and diagnostic contexts. Another notable patent involves the isolation of a nucleic acid molecule encoding a cancer-associated antigen, along with the antigen itself and its various uses. This work highlights her commitment to advancing cancer treatment and diagnostics.
Career Highlights
Throughout her career, Elke Jäger has worked with esteemed organizations, including the Ludwig Institute for Cancer Research Limited. Her research has significantly impacted the understanding and treatment of cancer, showcasing her dedication to scientific advancement.
Collaborations
She has collaborated with notable colleagues such as Lloyd J. Old and Yao-tseng Chen, further enhancing her contributions to the field.
Conclusion
Elke Jäger's innovative work in cancer research exemplifies her commitment to improving therapeutic and diagnostic methods. Her patents and collaborations reflect her significant impact on the scientific community.